Co-founder and Managing Director, John Kelly, chats with Phil Muscatello on The Equity ASA podcast, produced for the Australian Shareholders' Association. [audio mp3="https://atomodiagnostics.com/wp-content/uploads/2021/08/31-John-Kelly.mp3"][/audio] ...
The Australian covers our agreement with Joe Hockey’s firm Bondi Partners to help with our US launch. Read Article Here...
An article in The Market Herald on our support for Unitaid's quest to expand access to HIV self-testing in low- and middle-income countries. Read Article Here...
An article in 360DX on our deal, together with Viatris Inc., with UNITAID to expand access to HIV self-testing in low- and middle-income countries. Read Article Here...
MD John Kelly spoke to Alan Kohler about our point-of-care rapid tests. Read Article Here...
Our MD, John Kelly spoke to ABC News about the need for rapid antibody and antigen tests to be used in Australia. Read Article Here...
Stockhead lists Atomo Diagnostics as a stock to watch. Read Article Here...
The Motley Fool talks about Atomo Diagnostics’ share price rise. Read Article Here...
Harvard has begun to welcome back a limited number of students, faculty, academic personnel, and staff to our campus as conditions allow. They have deployed several strategies—including high-frequency viral testing for all community members who are authorized to have a regular presence on campus—to help...
An effective testing program is a crucial part of minimizing the spread of the virus in a community, and testing innovations adopted by MIT are helping in-person activities to resume on campus. Read Article Here...
An effective testing program is a crucial part of minimizing the spread of the virus in a community, and testing innovations developed by the University of Illinois Urbana-Champaign are helping in-person activities to resume on campus. Read Article Here...
Yale’s Screening Program consists of two components: testing and contact tracing. The program was designed to reduce the risk of outbreaks on campus and in the New Haven community, based on epidemiologic models and the best available data. Free viral testing is available to all faculty,...
Colleges are planning a wide range of testing strategies, ranging from frequent universal testing to no campus-based testing at all. Variation of approaches raises questions about equity. Different colleges are planning a wide range of testing approaches this fall. Some are planning on twice-weekly testing of...
It’s a sign of how well Australia has handled the pandemic that a single positive case in the community will make national headlines, while in many other countries thousands of people are dying from the disease every day. Our hotel quarantine system for returned travellers and...
Researchers at NSF International and Novateur Ventures screen rapid-detection tests for clinical sensitivity/specificity, limit of detection and time to results. Read Article Here...
Dozens of public and private sector employers are now offering rapid testing to those without symptoms. Businesses and public sector organisations are joining a government scheme to test workers without symptoms who cannot work from home. Around 1 in 3 people have no symptoms and may be...
Big banks, including Deutsche Bank and Bank of America, are testing employees for before they step into the office. Some banks are offering their staff lab-based PCR tests, which are considered the most accurate way of detecting the virus, but they can cost around $US100 to...
The Motley Fool covers Atomo’s December quarterly report and how the company is positioning itself for growth in 2021. Read Article Here ...
The Market Herald reports on Atomo’s positive December 2020 quarterly report. Read Article Here ...
Our MD John Kelly sat down with Ausbiz to talk about Atomo’s strong growth, our solid progress with commercialising our rapid diagnostics tests and securing licensing deals with partners. Watch the interview here ...
Atomo was featured in a recent article by Biotech Dispatch regarding the approval of Atomo’s rapid antigen test. Read Article Here ...
As WA and QLD take first steps to reopen borders, our CEO, John Kelly was asked to comment in the Australian Financial Review on how an antigen / antibody testing combo could help Australia to open up with more confidence. Read Article Here ...
Our MD, John Kelly was interviewed by Ausbiz about the approval for our rapid antigen test. Watch the Interview Here ...
Motley Fool talks about our share price gain following the Australian approval of our rapid antigen test. Read the full article > ...
The Market Herald discusses the approval for our rapid antigen test. Read the full article > ...
This Business News Australia discusses the benefits and convenience of the 10-minute Antigen test. Read the full article > ...
An article by Biotech Dispatch on our expanded partnership with Access Bio to launch a rapid antigen test in Australia, New Zealand and India. Read the full article > ...
Our MD, John Kelly sat down with Ausbiz to discuss our rapid antigen test deal with Access Bio which will enable screening for acute infection and exposure at the same time. Watch the Video ...
An article by Motley Fool on our expanded a partnership with Access Bio to launch a rapid antigen test in Australia, New Zealand and India. Read the full article > ...
Managing Director, John Kelly speaks to Proactive about the broad applications for Atomo’s rapid blood-based tests at the ASX Small and Mid-Cap Conference. [embed]https://www.youtube.com/watch?v=wl4xxnxZ198[/embed]...